Cargando…
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476239/ https://www.ncbi.nlm.nih.gov/pubmed/31040741 http://dx.doi.org/10.4103/wjnm.WJNM_117_18 |
| _version_ | 1783412871649034240 |
|---|---|
| author | Dizdarevic, S Tulchinsky, M McCready, VR Mihailovic, J Vinjamuri, S Buscombe, JR Lee, ST Frangos, S Sathekge, M Siraj, Q Choudhury, P Bom, H Franceschi, M Ugrinska, A Paez, D Hussain, R Mailman, J Luster, M Virgolini, I |
| author_facet | Dizdarevic, S Tulchinsky, M McCready, VR Mihailovic, J Vinjamuri, S Buscombe, JR Lee, ST Frangos, S Sathekge, M Siraj, Q Choudhury, P Bom, H Franceschi, M Ugrinska, A Paez, D Hussain, R Mailman, J Luster, M Virgolini, I |
| author_sort | Dizdarevic, S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6476239 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64762392019-04-30 The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma Dizdarevic, S Tulchinsky, M McCready, VR Mihailovic, J Vinjamuri, S Buscombe, JR Lee, ST Frangos, S Sathekge, M Siraj, Q Choudhury, P Bom, H Franceschi, M Ugrinska, A Paez, D Hussain, R Mailman, J Luster, M Virgolini, I World J Nucl Med Editorial Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6476239/ /pubmed/31040741 http://dx.doi.org/10.4103/wjnm.WJNM_117_18 Text en Copyright: © 2019 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Dizdarevic, S Tulchinsky, M McCready, VR Mihailovic, J Vinjamuri, S Buscombe, JR Lee, ST Frangos, S Sathekge, M Siraj, Q Choudhury, P Bom, H Franceschi, M Ugrinska, A Paez, D Hussain, R Mailman, J Luster, M Virgolini, I The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma |
| title | The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma |
| title_full | The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma |
| title_fullStr | The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma |
| title_full_unstemmed | The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma |
| title_short | The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma |
| title_sort | world association of radiopharmaceutical and molecular therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476239/ https://www.ncbi.nlm.nih.gov/pubmed/31040741 http://dx.doi.org/10.4103/wjnm.WJNM_117_18 |
| work_keys_str_mv | AT dizdarevics theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT tulchinskym theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT mccreadyvr theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT mihailovicj theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT vinjamuris theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT buscombejr theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT leest theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT frangoss theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT sathekgem theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT sirajq theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT choudhuryp theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT bomh theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT franceschim theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT ugrinskaa theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT paezd theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT hussainr theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT mailmanj theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT lusterm theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT virgolinii theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT theworldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT dizdarevics worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT tulchinskym worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT mccreadyvr worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT mihailovicj worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT vinjamuris worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT buscombejr worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT leest worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT frangoss worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT sathekgem worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT sirajq worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT choudhuryp worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT bomh worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT franceschim worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT ugrinskaa worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT paezd worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT hussainr worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT mailmanj worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT lusterm worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT virgolinii worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma AT worldassociationofradiopharmaceuticalandmoleculartherapypositionstatementontheinitialradioiodinetherapyfordifferentiatedthyroidcarcinoma |